Axon Loss in the Spinal Cord Determines Permanent Neurological Disability in an Animal Model of Multiple Sclerosis
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Most patients undergo an initial relapsing-remitting (RR-MS) course that transforms into a relentless neurodegenerative disorder, termed secondary progressive (SP)-MS. Reversible inflammation and demyelination account readily for the pattern of RR-MS but provide an unsatisfactory explanation for irrevocable decline in SP-MS. Axon loss is thought to be responsible for progressive, non-remitting neurological disability during SP-MS. There is considerable potential for neuroprotective therapies in MS, but their application awaits animal models in which axonal loss correlates with permanent neurological disability. In this report, we describe quantitative immunohistochemical methods that correlate inflammation and axonal loss with neurological disability in chronic-relapsing experimental autoimmune encephalomyelitis (EAE). At first attack, CNS inflammation, but not axon loss, correlated with the degree of neurological disability. In contrast, fixed neurological impairment in chronic EAE correlated with axon loss that, in turn, correlated with the number of symptomatic attacks. As proposed for MS, these observations imply a causal relationship between inflammation, axon loss, and irreversible neurological disability. This chronic-relapsing EAE model provides an excellent platform for 2 critical objectives: investigating mechanisms of axon loss and evaluating efficacy of neuroprotective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Self-citationNoseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Losseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H., & Thompson, A. J. (1996) · Brain · doi:10.1093/brain/119.3.701 · Cited by 643
Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions
Traugott, U., Reinherz, E. L., & Raine, C. S. (1983) · Science · doi:10.1126/science.6217550 · Cited by 421
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
Martin, R., McFarland, H. F., & Boggs, J. M. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084683 · Cited by 376 · cited 3×
“Inflammatory swelling is prominent in the CNS tissues of acute EAE mice and varies according to clinical score.”
BackgroundHohlfeld, R. (1997) · Brain · doi:10.1093/brain/120.5.865 · Cited by 365
Axonal changes in chronic demyelinated cervical spinal cord plaques
Lovas, G., Szilagyi, N., Majtenyi, K., Palkovits, M., & Komoly, S. (2000) · Brain · doi:10.1093/brain/123.2.308 · Cited by 356
McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martin, R., Harris, J. O., Patronas, N., Maloni, H., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 346
Spinal cord MRI using multi‐array coils and fast spin echo: II. Findings in multiple sclerosis
Kidd, D., Thorpe, J. W., Thompson, A. J., Kendall, B. E., Moseley, I. F., MacManus, D. G., McDonald, W. I., & Miller, D. H. (1993) · Neurology · doi:10.1212/wnl.43.12.2632 · Cited by 340
Harris, J. O., Frank, J. A., Patronas, N., McFarlin, D. E., & McFarland, H. F. (1991) · Annals of Neurology · doi:10.1002/ana.410290515 · Cited by 303
A comparison of the pathology of primary and secondary progressive multiple sclerosis
Revesz, T., Kidd, D., Thompson, A. J., Barnard, R. O., & McDonald, W. I. (1994) · Brain · doi:10.1093/brain/117.4.759 · Cited by 293
Animal models for autoimmune demyelinating disorders of the nervous system
Gold, R., Hartung, H.-P., & Toyka, K. V. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01639-1 · Cited by 292 · cited 2×
“In Lewis rats immunized with myelin basic protein (MBP) or in outbred rhesus macaques immunized with bovine brain homogenate, EAE is a hyperacute disease consisting of neutrophil and T-cell inflammation and limited demyelination (9, 16).”
BackgroundProgress in determining the causes and treatment of multiple sclerosis
Noseworthy, J. H. (1999) · Nature · doi:10.1038/399a040 · Cited by 278
The longstanding MS lesion. A quantitative MRI and electron microscopic study
BARNES, D., MUNRO, P. M. G., YOUL, B. D., PRINEAS, J. W., & MCDONALD, W. I. (1991) · Brain · doi:10.1093/brain/114.3.1271 · Cited by 256
Bö, L., Mörk, S., Kong, P. A., Nyland, H., Pardo, C. A., & Trapp, B. D. (1994) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)90075-2 · Cited by 256
Self-citationTancredi, V., D'Antuono, M., Cafè, C., Giovedì, S., Buè, M. C., D'Arcangelo, G., Onofri, F., & Benfenati, F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750634.x · Cited by 249
The role of CD45 and CD45‐associated molecules in T cell activation
Altin, J. G., & Sloan, E. K. (1997) · Immunology & Cell Biology · doi:10.1038/icb.1997.68 · Cited by 217
Demyelinating Diseases -- New Pathological Insights, New Therapeutic Targets
Waxman, S. G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380510 · Cited by 211
Matsumoto, Y., Hara, N., Tanaka, R., & Fujiwara, M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.10.3668 · Cited by 203
Spinal cord axonal loss in multiple sclerosis: a post‐mortem study
Ganter, Prince, & Esiri (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00205.x · Cited by 202
Rivera-Quiñones, C., McGavern, D., Schmelzer, J. D., Hunter, S. F., Low, P. A., & Rodriguez, M. (1998) · Nature Medicine · doi:10.1038/nm0298-187 · Cited by 196
Neurodegeneration in Multiple Sclerosis: Relationship to Neurological Disability
Trapp, B. D., Ransohoff, R. M., Fisher, E., & Rudick, R. A. (1999) · The Neuroscientist · doi:10.1177/107385849900500107 · Cited by 190
Self-citationBerger, T., Weerth, S., Kojima, K., Linington, C., Wekerle, H., & Lassmann, H. (1997) · PubMed · Cited by 185
Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis
Comi, G., Filippi, M., Martinelli, V., Campi, A., Rodegher, M., Alberoni, M., Sirabian, G., & Canal, N. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00168-2 · Cited by 185
Matthews, P., De Stefano, N., Narayanan, S., Francis, G., Wolinsky, J., Antel, J., & Arnold, D. (1998) · Seminars in Neurology · doi:10.1055/s-2008-1040884 · Cited by 178
Barkhof, F., Scheltens, P., Frequin, S. T., Nauta, J. J., Tas, M. W., Valk, J., & Hommes, O. R. (1992) · American Journal of Roentgenology · doi:10.2214/ajr.159.5.1414773 · Cited by 165
Butterfield, R. J., Sudweeks, J. D., Blankenhorn, E. P., Korngold, R., Marini, J. C., Todd, J. A., Roper, R. J., & Teuscher, C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1860 · Cited by 152
Hickey, W. F., Gonatas, N. K., Kimura, H., & Wilson, D. B. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.6.2805 · Cited by 147
Interferon-β inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis
Yu, M., Nishiyama, A., Trapp, B. D., & Tuohy, V. K. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00160-3 · Cited by 147
Self-citation't Hart, B. A., Bauer, J., Muller, H.-J., Melchers, B., Nicolay, K., Brok, H., Bontrop, R. E., Lassmann, H., & Massacesi, L. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65606-4 · Cited by 146
Kabat, E. A., Wolf, A., & Bezer, A. E. (1946) · Science · doi:10.1126/science.104.2703.362 · Cited by 141
Shi, R., & Blight, A. R. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.1572 · Cited by 121
Butterfield, R. J., Blankenhorn, E. P., Roper, R. J., Zachary, J. F., Doerge, R. W., & Teuscher, C. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64574-9 · Cited by 111
A spinal cord MRI study of benign and secondary progressive multiple sclerosis
Filippi, M., Campi, A., Colombo, B., Pereira, C., Martinelli, V., Baratti, C., & Comı, G. (1996) · Journal of Neurology · doi:10.1007/bf00886870 · Cited by 110
Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
Genain, C. P., & Hauser, S. L. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050103 · Cited by 90
Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit
Brosnan, C. F., Litwak, M. S., Schroeder, C. E., Selmaj, K. W., Raine, C. S., & Arezzo, J. C. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90141-0 · Cited by 82
Magnetic resonance spectroscopy: imaging axonal damage in MS
Arnold, D. L. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00074-0 · Cited by 74
Nerve Conduction Block by Nitric Oxide That Is Mediated by the Axonal Environment
Shrager, P. G., Custer, A. W., Kazarinova-Noyes, K., Rasband, M. N., & Mattson, D. H. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.2.529 · Cited by 67
IN‐SITU CHARACTERIZATION OF MONONUCLEAR CELL INFILTRATES IN LESIONS OF MULTIPLE SCLEROSIS
Nyland, H., Mørk, S. J., & Matre, R. (1982) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1982.tb00308.x · Cited by 43
Sobel, R. A., van der Veen, R. C., & Lees, M. B. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.1.157 · Cited by 40
Jc, A., Brosnan, C. F., Schroeder, C. E., Litwak, M. S., & Bornstein, M. B. (1988) · Brain Research · doi:10.1016/0006-8993(88)90557-4 · Cited by 20
Kordower (1999) · doi:10.1002/1531-8249(199909)46:3
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Pathological mechanisms in progressive multiple sclerosis
Mahad, D. H., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,137
Self-citationInfiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“Experimental studies soon showed parallel findings in EAE (Kornek et al., 2001; Wujek et al., 2002), and identified specific molecular abnormalities such as redistribution of ion channels on chronically demyelinated axons that may play an important role in the axonal pathology of multiple sclerosis (Kornek et al.”
Background
Metadata
- Authors
- Wujek, J. R., Bjartmar, C., Richer, E., Ransohoff, R. M., Yu, M., Tuohy, V. K., & Trapp, B. D.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-01
- Volume
- 61
- Issue
- 1
- Pages
- 23-32
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- OpenAlex
- W197245174
- Cited by
- 289
- References
- 47
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.